Skip to main content
. 2018 Apr 24;9(18):4299–4307. doi: 10.1039/c8sc00428e

Fig. 1. Structures of the three Pt(ii) drugs approved by FDA as well as satraplatin (top) and examples of dual action Pt(iv) prodrugs with DPKi (DCA), COXis (ASP and Ibu) and HDACis (Val and PhB) (bottom).

Fig. 1